Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Nonmelanoma Skin Cancer

Treatment of Nonmelanoma Skin Cancer Letters 2. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant Basal cell carcinoma: To the Editor Linos et al present a study questioning the value clinicopathological analysis of 51 cases and review of the literature. Anticancer and current methods of treatment of nonmelanoma skin can- Res. 2009;29(7):2655-2663. Review. cer (NMSC) in elderly patients. Multiple and serious flaws ex- 3. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: ist in their study methods, results, and conclusions. estimated incidence of disease, nodal metastasis, and deaths from disease in First, the authors refer to NMSCs as “nonmalignant skin the United States, 2012. J Am Acad Dermatol. 2013;68(6):957-966. cancers.” This statement is factually inaccurate and their cat- 4. Merritt BG, Lee NY, Brodland DG, Zitelli JA, Cook J. The safety of Mohs surgery: a prospective multicenter cohort study. J Am Acad Dermatol. egorization demonstrates bias. Patients do die of basal cell 2 2012;67(6):1302-1309. carcinoma, and many more patients each year die of squa- 5. Connolly SM, Baker DR, Coldiron BM, et al; Ad Hoc Task Force; Ratings Panel. mous cell carcinoma. Low morbidity and mortality are ob- AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic served for NMSCs because they http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Treatment of Nonmelanoma Skin Cancer

JAMA Internal Medicine , Volume 173 (22) – Dec 9, 2013

Treatment of Nonmelanoma Skin Cancer

Abstract

Letters 2. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant Basal cell carcinoma: To the Editor Linos et al present a study questioning the value clinicopathological analysis of 51 cases and review of the literature. Anticancer and current methods of treatment of nonmelanoma skin can- Res. 2009;29(7):2655-2663. Review. cer (NMSC) in elderly patients. Multiple and serious flaws ex- 3. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: ist in their study methods, results,...
Loading next page...
 
/lp/american-medical-association/treatment-of-nonmelanoma-skin-cancer-UwIgSe0beh

References (5)

Publisher
American Medical Association
Copyright
Copyright 2013 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2013.10429
pmid
24322470
Publisher site
See Article on Publisher Site

Abstract

Letters 2. Archontaki M, Stavrianos SD, Korkolis DP, et al. Giant Basal cell carcinoma: To the Editor Linos et al present a study questioning the value clinicopathological analysis of 51 cases and review of the literature. Anticancer and current methods of treatment of nonmelanoma skin can- Res. 2009;29(7):2655-2663. Review. cer (NMSC) in elderly patients. Multiple and serious flaws ex- 3. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: ist in their study methods, results, and conclusions. estimated incidence of disease, nodal metastasis, and deaths from disease in First, the authors refer to NMSCs as “nonmalignant skin the United States, 2012. J Am Acad Dermatol. 2013;68(6):957-966. cancers.” This statement is factually inaccurate and their cat- 4. Merritt BG, Lee NY, Brodland DG, Zitelli JA, Cook J. The safety of Mohs surgery: a prospective multicenter cohort study. J Am Acad Dermatol. egorization demonstrates bias. Patients do die of basal cell 2 2012;67(6):1302-1309. carcinoma, and many more patients each year die of squa- 5. Connolly SM, Baker DR, Coldiron BM, et al; Ad Hoc Task Force; Ratings Panel. mous cell carcinoma. Low morbidity and mortality are ob- AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic served for NMSCs because they

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Dec 9, 2013

There are no references for this article.